R21 funding to prepare rare disease therapies and diagnostics for future clinical trials
PAR-25-450This NOFO funds research to build clinical trial readiness for rare diseases. Projects may develop and test biomarkers, clinical outcome measures, or define disease presentation and course to inform future trial design. Clinical trials are not allowed under this R21 mechanism.
This Notice of Funding Opportunity (NOFO) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare diseases research by enabling ef…
Source
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving…
Tags
Supporting links
Documents
Similar opportunities
-
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
-
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
-
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
-
Funding for Rare Diseases Clinical Research Consortia in the RDCRN (U54; clinical trials optional)
-
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers